Drug is being reviewed for ALK-positive lung cancer
Submission based on results from phase I CHRYSALIS study
Shot was approved by MHRA on 30 December
The discovery of new drugs is vital to achieving the eradication of neglected tropical diseases (NTDs) in Africa […]
A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed […]
The NHS in England faces unprecedented challenges in 2021. It will require an equally unprecedented, and long term, […]
Khunti and colleagues eloquently explain the problematic use of the acronyms BAME (black, Asian, and minority ethnic) and […]
Hospitals across London and the South East and East of England are struggling to meet rising demand as […]
Healthcare workers in England have been told to reschedule appointments for the second dose of the Pfizer and […]
